Subscribe: Health
http://rss.prnewswire.com/industry/health-biotech
Added By: Feedage Forager Feedage Grade A rated
Language: English
Tags:
announced today  cancer  care  managed care  march prnewswire  march  market  new york  new  prnewswire  today  york march 
Rate this Feed
Rate this feedRate this feedRate this feedRate this feedRate this feed
Rate this feed 1 starRate this feed 2 starRate this feed 3 starRate this feed 4 starRate this feed 5 star

Comments (0)

Feed Details and Statistics Feed Statistics
Preview: Health

PR Newswire: Health



Press Releases from PR Newswire about Health



Published: Tue, 28 Mar 2017 21:35:58 EDT

Last Build Date: Tue, 28 Mar 2017 21:18:00 EDT

 



DKT de México anuncia campaña sobre Salud Sexual y Reproductiva en adolescentes: #DobleSiempreEsMejor

Tue, 28 Mar 2017 21:18:00 EDT

(image) CIUDAD DE MEXICO, 28 de marzo de 2017 /PRNewswire/ -- En el marco del Día Internacional de la Mujer, DKT de México presentó la campaña #DobleSiempreEsMejor, que busca impactar a los 17.5 millones de jóvenes entre 12 y 19 años que viven en nuestro país, a fin de brindarles información,...



Media Files:
http://www.dkt.com.mx




Veteran's Son Shares New PTSD System For Vietnam Veterans Day

Tue, 28 Mar 2017 20:20:00 EDT

NEW YORK, March 28, 2017 /PRNewswire/ -- For over fifteen years, author and stress relief expert Brett Cotter has been developing and sharing his relaxation tools in companies, schools, and non-profits. With multiple generations of combat veterans in his own family, and seeing too many...



Center Point Clinical Services' Studies Show That Pharmacist-led Interventions Increase Clinical Trial Patient Medication Adherence and Compliance and Provide Robust Study Data

Tue, 28 Mar 2017 20:00:00 EDT

(image) MALVERN, Pennsylvania, March 29, 2017 /PRNewswire/ -- Center Point Clinical Services, creator of the world's first Siteless CRO platform, announced today study results presented in two separate posters at the Academy of Managed Care Pharmacy, #AMCP2017, Managed Care and Specialty...



Media Files:
http://photos.prnewswire.com/prn/20160317/345390LOGO




Dreamit Health Announces Spring 2017 Cohort Of Startups In Partnership With Penn Medicine And Independence Blue Cross

Tue, 28 Mar 2017 17:27:00 EDT

(image) NEW YORK and PHILADELPHIA, March 28, 2017 /PRNewswire/ -- Leading global startup accelerator Dreamit announced today the new cohort of companies accepted into its spring 2017 cycle. The eight accepted companies are leading the transformation of healthcare, using emerging technologies to...



Media Files:
http://www.ibx.com




New Glaucoma Treatment Performed by Eva I. Liang, M.D. F.A.C.S. in Las Vegas

Tue, 28 Mar 2017 17:19:00 EDT

(image) LAS VEGAS, March 28, 2017 /PRNewswire/ -- Las Vegas ophthalmology practice, Center For Sight, announced today the first surgeries with XEN45 Gel Stent (Allergan, Dublin), an implant that shunts excess fluid built up in the eye, thereby reducing intraocular pressure in patients with...



Media Files:
http://www.centerforsightlv.com




Teamster Mechanics Protest Cummins Health Care Cuts At Mid-America Trucking Show

Tue, 28 Mar 2017 17:09:00 EDT

(image) LOUISVILLE, Ky., March 28, 2017 /PRNewswire-USNewswire/ -- Last weekend, Cummins engine mechanics and service workers from West Virginia attended the Mid-America Trucking Show to protest Cummins' (NYSE:CMI) unaffordable health insurance. Over the course of two days, Cummins employees...



Media Files:
https://mma.prnewswire.com/media/33969/international_brotherhood_of_teamsters_logo.jpg




NFL Pro Football Hall of Famer and Oral Cancer Survivor Jim Kelly Urges Public to Attend Free Local Screenings During Oral, Head and Neck Cancer Awareness Week®

Tue, 28 Mar 2017 17:01:00 EDT

(image) CHARLESTON, S.C., March 28, 2017 /PRNewswire/ -- Jim Kelly, former Buffalo Bills quarterback and an oral cancer survivor, is urging Americans to get screened for cancer during the 19th annual Oral, Head & Neck Cancer Awareness Week® (OHANCAW®), being held worldwide April 2-9, 2017....



Media Files:
https://mma.prnewswire.com/media/483511/Head_and_Neck_Cancer_Alliance_Jim_Kelly.jpg




Academy of Managed Care Pharmacy (AMCP) Opens AMCP Managed Care & Specialty Pharmacy Annual Meeting

Tue, 28 Mar 2017 16:47:00 EDT

(image) DENVER, March 28, 2017 /PRNewswire-USNewswire/ -- Four thousand managed care pharmacy professionals and stakeholders from across the country have traveled to Denver, Colorado, this week for the Academy of Managed Care Pharmacy (AMCP) Managed Care & Specialty Pharmacy Annual Meeting....



Media Files:
http://www.amcp.org




Athenex Announces the US FDA Allowance of the Investigational New Drug Application of Oratopo, A Combination of HM30181A and Oral Topotecan For the Treatment of Advanced Cancer

Tue, 28 Mar 2017 16:40:00 EDT

BUFFALO, N.Y. and HONG KONG, March 28, 2017 /PRNewswire/ -- Athenex, Inc., a global specialty oncology pharmaceutical company focused on the development and commercialization of next generation therapies for cancer diseases and supportive therapies, announced today that it has received...



Disposable Blood Pressure Cuffs Market Analysis By Call Points (Surgeons, Physician, Clinicians), By Region (North America, Europe, Asia Pacific, Latin America, MEA) And Segment Forecasts, 2014 - 2025

Tue, 28 Mar 2017 16:40:00 EDT

(image) NEW YORK, March 28, 2017 /PRNewswire/ -- The global disposable blood pressure cuffs market is expected to reach USD 356.8 million by 2025, according to a new study by Grand View Research, Inc. The market is driven by the growing adoption of disposable BP cuffs by healthcare...



Media Files:
http://www.reportlinker.com




Diplomat to Dispense DUPIXENT® to Treat Atopic Dermatitis

Tue, 28 Mar 2017 16:33:00 EDT

(image) FLINT, Mich., March 28, 2017 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO) will have access to dispense DUPIXENT® (dupilumab), recently approved by the Food and Drug Administration to treat adult patients who have inadequately controlled moderate-to-severe atopic dermatitis....



Media Files:
https://mma.prnewswire.com/media/148820/diplomat_specialty_pharmacy_logo.jpg




Nucleic Acid Amplification Testing Market Analysis By Application (Infectious Diseases, Cancer, Personalized Medicine, Genetic), By Technique (target amplification, probe amplification, & signal amplification), And Segment Forecasts, 2014 - 2025

Tue, 28 Mar 2017 16:22:00 EDT

(image) NEW YORK, March 28, 2017 /PRNewswire/ -- The global nucleic acid amplification test (NAAT) market is expected to reach USD 4.4 Billion by 2025, according to a new report by Grand View Research, Inc. Nucleic acid amplification testing is gaining preference over traditional diagnostic...



Media Files:
http://www.reportlinker.com




Ultrasound Image Analysis Software Market Size & Forecast By Software Type (Integrated, Standalone), By Product (2D, 3D & 4D, Doppler), By Application (Cardiology, Obstetrics & Gynecology, Radiology, Oncology) And Trend Analysis From 2014 To 2025

Tue, 28 Mar 2017 16:21:00 EDT

(image) NEW YORK, March 28, 2017 /PRNewswire/ -- The global ultrasound image analysis software market is expected to reach USD 1.2 billion by 2025, according to a new study by Grand View Research, Inc. The growing prevalence of chronic diseases is a high impact rendering growth driver for the...



Media Files:
http://www.reportlinker.com




Orexigen Therapeutics Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2016

Tue, 28 Mar 2017 16:21:00 EDT

(image) SAN DIEGO, March 28, 2017 /PRNewswire/ -- Orexigen Therapeutics, Inc. (Nasdaq: OREX) today announced business and financial results for the fourth quarter and year ended December 31, 2016. "Last year was a year of transformational progress for Orexigen, beginning with the...



Media Files:
http://www.orexigen.com




Chemotherapy Induced Neutropenia (CIN) - Market Insights, Epidemiology and Market Forecast - 2023

Tue, 28 Mar 2017 16:16:00 EDT

(image) NEW YORK, March 28, 2017 /PRNewswire/ -- "Chemotherapy Induced Neutropenia (CIN) – Market Insights, Epidemiology and Market Forecast-2023" Report provides an overview of the disease and global market trends of the Chemotherapy Induced Neutropenia for the seven major markets i.e., United...



Media Files:
http://www.reportlinker.com




Interpace Diagnostics Group Announces Timing of Earnings Release and Investor Conference Call

Tue, 28 Mar 2017 16:05:00 EDT

PARSIPPANY, N.J., March 28, 2017 /PRNewswire/ -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG) (the "Company"), a fully integrated commercial company that provides clinically useful molecular diagnostic tests and pathology services, announced today that it will release 2016 year end...



DC Coalition to End Sexual Violence, A Partnership Between Men Can Stop Rape and DC Rape Crisis Center

Tue, 28 Mar 2017 16:04:00 EDT

WASHINGTON, March 28, 2017 /PRNewswire-USNewswire/ -- Like the rest of the nation, the District of Columbia is recognizing National Sexual Assault Awareness Month (SAAM) in April with many opportunities to learn about preventing and ending sexual assault and supporting survivors. SAAM...



2017 France Microbiology Automated Market: Supplier Shares and Strategies, Country Segment Forecasts, Technology Trends, Instrumentation Review--Molecular Diagnostics, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screeni

Tue, 28 Mar 2017 16:02:00 EDT

(image) NEW YORK, March 28, 2017 /PRNewswire/ -- Complete report $6,950. DataPack (test volumes, sales forecasts, supplier shares) $4,500. VPGMarketResearch.com's new report is an analysis of major business opportunities emerging in the French automated microbiology market during the next...



Media Files:
http://www.reportlinker.com




Volition America, Inc. Retains Strategic Expert in Securing Non-Dilutive Funding Opportunities in the United States

Tue, 28 Mar 2017 16:01:00 EDT

NAMUR, Belgium, March 28, 2017 /PRNewswire/ -- Volition America, Inc., a wholly-owned U.S. subsidiary of VolitionRx Limited (NYSE MKT: VNRX), today announced the engagement of Deborah Vollmer Dahlke, DrPH, CEO and President of DVD Associates, LLC, as a strategic consultant. Dr. Vollmer...



Asterias Biotherapeutics Reports Fourth Quarter and Full Year 2016 Financial Results and Highlights Recent Development Progress

Tue, 28 Mar 2017 16:01:00 EDT

(image) FREMONT, Calif., March 28, 2017 /PRNewswire/ -- Asterias Biotherapeutics, Inc. (NYSE MKT: AST), a biotechnology company pioneering the field of regenerative medicine, today reported financial and operational results for the fourth quarter and year ended December 31, 2016 as well as  recent...



Media Files:
http://www.asteriasbiotherapeutics.com